A coalition of dietary supplement industry trade associations have come out in support of FDA actions against fraudulent coronavirus treatment claims and have urged retailers to not stock products with such claims on their labels.
The dietary supplement industry has an opportunity to communicate with a new range of consumers in light of the current crisis. Highlighting the excellent safety of the products and quality initiatives underway can help keep the embarrassment of rampant...
The Botanical Adulteration Prevention Program has issued a lab guidance document on turmeric. The publication is timely as interest in the botanical, which was already high, has spiked during the current coronavirus crisis.
The $2 trillion stimulus packaged passed unanimously by the US Senate this morning will have important implications for the dietary supplement industry that may help companies survive the worst of the coronavirus crisis impacts.
Synthetic astaxanthin product developer Cardax has released a white paper and reportedly filed a patent application on the ingredient’s antiviral properties and in publicizing the fact has treaded on the disease claim line according to legal experts.
Dietary supplement manufacturers and the natural channel stores that sell the products play an important role in supporting consumers health during this challenging time and should be counted as ‘essential’ businesses, stakeholders say.
While the COVID-19 crisis dominates headlines, a raft of state and local laws that could negatively affect the dietary supplement industry are afoot and deserve attention, according the Council for Responsible Nutrition.